Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €1.23 EUR
Change Today 0.00 / 0.00%
Volume 0.0
BIG1 On Other Exchanges
As of 3:36 AM 10/2/15 All times are local (Market data is delayed by at least 15 minutes).

bio-gate ag (BIG1) Snapshot

Previous Close
Day High
Day Low
52 Week High
05/19/15 - €1.78
52 Week Low
05/8/15 - €1.10
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BIO-GATE AG (BIG1)

Related News

No related news articles were found.

bio-gate ag (BIG1) Related Businessweek News

No Related Businessweek News Found

bio-gate ag (BIG1) Details

Bio-Gate AG, a medical technology company, develops and markets applications using silver technology to prevent infections. It provides plasma coatings, including HyProtect that offers protection for the surfaces of medical implants and instruments against bacterial contamination. The company also provides antimicrobial agents, which include MicroSilver BG-Med made of pure metallic silver for medical technology applications; MicroSilver BG for cosmetic applications; and MicroSilver BG-Tec for hygiene-sensitive applications in industries and consumer goods, as well as offers product development and product registration support services. Its products are applied in medical devices and packaging; orthopedics, wound care, catheters, cardiology, implants, and dental products; industrial applications comprising industrial systems, food technology, and transportation systems; consumer goods, including electronics, white goods, and textiles; and cosmetics consisting of skin care, and hygiene-sensitive applicators and dosing units. The company is headquartered in Nuremberg, Germany. Bio-Gate AG operates as a subsidiary of Suyntos-Beteiligungs GmbH

bio-gate ag (BIG1) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

bio-gate ag (BIG1) Key Developments

Bio-Gate AG, Annual General Meeting, May 20, 2015

Bio-Gate AG, Annual General Meeting, May 20, 2015.

Bio-Gate AG Signs License Agreement with VetBiotek, Inc

Bio-Gate AG has signed a license agreement with VetBiotek, Inc. for marketing and distribution of dermatological products for the veterinary market with MicroSilver BG(TM) technology in the US and Canada. MicroSilver BG(TM) technology is a pure silver powder consisting of porous and micro-sized particles of medical-grade silver. Additionally, VetBiotek has also secured the exclusive North American marketing rights for Bio-Gate's ear care system of products for managing otitis externa, a chronic disease in pets. This system utilizes a protocol of quality products, all of which also contain MicroSilver BG(TM).

Bio Gate AG Announces Earnings Results for 2013

Bio Gate AG announced earnings results for 2013. For the year, the company’s net loss narrowed to EUR 1.5 million from a loss of EUR 2.2 million in 2012. The loss before interest, tax, depreciation and amortization (LBITDA) shrank to EUR 1.1 million from EUR 1.7 million. Revenue rose by nearly 10% to EUR 2.5 million from EUR 2.3 million as the company managed to cut costs at key divisions.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIG1:GR €1.23 EUR 0.00

BIG1 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BIG1.
View Industry Companies

Industry Analysis


Industry Average

Valuation BIG1 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.4x
Price/Book 8.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIO-GATE AG, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at